Genus plc (LON:GNS – Get Free Report) shares reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as GBX 2,007 and last traded at GBX 2,012, with a volume of 147657 shares. The stock had previously closed at GBX 2,060.
Analysts Set New Price Targets
Separately, Berenberg Bank reiterated a “buy” rating and set a GBX 3,350 price objective on shares of Genus in a research report on Monday, May 11th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock presently has an average rating of “Buy” and an average price target of GBX 3,216.67.
Check Out Our Latest Research Report on GNS
Genus Trading Down 1.8%
Insider Buying and Selling
In other news, insider Jorgen Kokke sold 3,450 shares of Genus stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of GBX 2,267, for a total value of £78,211.50. Also, insider Celia Baxter bought 2,336 shares of Genus stock in a transaction dated Friday, June 26th. The shares were acquired at an average cost of GBX 2,140 per share, for a total transaction of £49,990.40. Corporate insiders own 0.71% of the company’s stock.
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Read More
- Five stocks we like better than Genus
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
